Introduction of allergenic foods after treatment with omalizumab.
Saved in:
| Title: | Introduction of allergenic foods after treatment with omalizumab. |
|---|---|
| Authors: | Dantzer J; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: jwrubel1@jh.edu., Virkud Y; Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC., Wang J; Elliot and Roslyn Jaffe Food Allergy Institute, Division of Allergy and Immunology, Kravis Children's Hospital, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY., Sicherer S; Elliot and Roslyn Jaffe Food Allergy Institute, Division of Allergy and Immunology, Kravis Children's Hospital, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY., Groetch M; Elliot and Roslyn Jaffe Food Allergy Institute, Division of Allergy and Immunology, Kravis Children's Hospital, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY., Shreffler W; Division of Pediatric Allergy and Immunology and Food Allergy Center, Massachusetts General Hospital, Boston, Mass., Pyle D; Division of Pediatric Allergy and Immunology and Food Allergy Center, Massachusetts General Hospital, Boston, Mass., Kim E; Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC., Keet C; Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC., Kulis M; Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC., Mudd K; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md., Sindher S; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, Calif., Long A; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, Calif., Scurlock AM; University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Ark., Jones SM; University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Ark., Leung D; National Jewish Health, Denver, Colo., Lanser B; National Jewish Health, Denver, Colo., Vickery B; Division of Allergy and Immunology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Ga., Ezhuthachan ID; Division of Allergy and Immunology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Ga., Bird JA; Department of Pediatrics and Internal Medicine, University of Texas Southwestern, Dallas, Tex., Parrish C; Department of Pediatrics and Internal Medicine, University of Texas Southwestern, Dallas, Tex., Spergel JM; Division of Allergy and Immunology, Department of Pediatrics at Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pa., Brown-Whitehorn T; Division of Allergy and Immunology, Department of Pediatrics at Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pa., Ligueros-Saylan M; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Tassinari P; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Iqbal A; Genentech/Roche, South San Francicso, Calif., Sibanda D; Genentech/Roche, South San Francicso, Calif., Huckabee C; Rho, Inc, Chapel Hill, NC., Yovetich N; Rho, Inc, Chapel Hill, NC., Rogers N; Rho, Inc, Chapel Hill, NC., Lin A; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Wheatley LM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Togias A; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Chinthrajah RS; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, Calif., Wood RA; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. |
| Source: | The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2025 Aug; Vol. 156 (2), pp. 394-405. Date of Electronic Publication: 2025 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
